pharmaceutical investing EyePoint Pharmaceuticals Announces Pricing of Public Offering of Common Stock
EyePoint Pharmaceuticals Reports Fiscal 2018 Fourth Quarter & Full Year Financial Results and Highlights Recent Progress
US Capital Global Facilitates $50MM Financing to Accelerate Charbone Hydrogen's North American Expansion
